PRIMECAP Management's position in CVS Health is currently worth $230M. That's 0.14% of their equity portfolio (105th largest holding). The first CVS Health trade was made in Q1 2013. Since then PRIMECAP Management bought shares seventeen more times and sold shares on 34 occasions. The stake costed the investor $169M, netting the investor a gain of 36% so far.
CVS Health Corporation is a top S&P 500 performer in 2025, up 78% YTD, with strong operational and financial momentum. I reiterate a Buy rating for CVS, rais...
New CVS Health chief executive officer David Joyner promoted an internal executive, Prem Shah, as group president of the company and hired former UnitedHealt...
Glenview Capital Management, a hudge fund that has been subject of certain media reports that it was pushing CVS Health management to break up the healthcare...
CVS has faced consecutive guidance downgrades and a significant share price drop due to underperformance in its Medicare Advantage segment and rising costs. ...